BNET Business Dictionary
Business Definition for: Clinical Trial
- a statistical study of human subjects to determine the effectiveness of a medical treatment
Additional Resources
- FDA, Clinical Trial Calendar Updates: AMAG Pharma, Immunomedics
- Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars. The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision...
- External links 2009-05-12
- Should I Enter a Clinical Trial? a Patient Reference Guide for Adults With a Serious or Life-Threatening Illness
- This Patient Reference Guide includes a summary of ECRI's technical report that evaluated the available research evidence about why patients enter clinical trials and how well patients who receive edical care in a clinical trial do compared to patients treated for the same health condition outside a clinical trial. The...
- White papers 2002-02-01
- ROI Value Driver Study for PalmOne Mobile Solutions: Clinical Trials - palmOne and PHT: Fulfilling the Promise of Clinical Trial Diary Research
- The process of developing and testing a new drug is lengthy, risky and costly. With the 20-year patent clock ticking from the time the Investigational New Drug application IND is submitted, over half of the patent-protected life is consumed developing, testing and seeking FDA approval. The paper highlights the clinical...
- White papers 2004-06-01
- FDA, Clinical Trial Calendar Updates: Thoratec, Allos Therapeutics
- Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars. The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision...
- External links 2009-04-21
- U.S. Clinical Trial Management Systems Markets Provides an In-depth Analysis of the U.S. Clinical Trial Management Systems Market
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c90962) has announced the addition of the Frost & Sullivan report "U.S. Clinical Trial Management Systems Markets" to their offering. This research service provides an in-depth analysis of the U.S. clinical trial management systems market. The research service includes revenue forecasts, data management...
- Research articles 2008-05-06
- Clinical Trial Shows Device Optimizes Cardiac Resynchronization Therapy in Less Than Two Minutes; St. Jude Medical Announces QuickOpt Optimization Clinical Trial Results and European Regulatory Approvals at Cardiostim 2006
- ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the clinical trial results, receipt of European CE Mark approval and European market launch of its QuickOptTM Timing Cycle Optimization. The trial results were presented by James G. Porterfield, M.D., principal investigator in the trial conducted under a U.S....
- Research articles 2006-06-16
- Chiron and XOMA Announce Initiation of Phase I Clinical Trial for CHIR-12.12 in Multiple Myeloma — Second Clinical Trial Evaluating Oncology Drug Candidate Begins
- EMERYVILLE, Calif. & BERKELEY, Calif. -- Chiron Corporation (Nasdaq:CHIR) and XOMA Ltd. (Nasdaq:XOMA) today announced the initiation of a second clinical trial of CHIR-12.12, a novel, fully human, antagonist antibody that targets the CD40 antigen. The Phase I trial is for patients with multiple myeloma, a type of cancer that...
- Research articles 2005-10-13
- FDA, Clinical Trial Calendar Updates: Discovery, Impax Labs
- Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars. The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision...
- External links 2009-04-21
- Callisto Pharmaceuticals Clinical Study of Anti-Leukemia Drug L-Annamycin Expanded to Third Clinical Site; Roswell Park Cancer Institute Commences Enrollment of Adult Leukemia Patients in Phase I/IIa Clinical Trial
- NEW YORK -- Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, today announced the expansion of its ongoing research trial of L-Annamycin, the Company's drug candidate to treat adult patients with relapsed or refractory acute lymphocytic leukemia...
- Research articles 2006-03-21
- Crucell/Aeras Start Turberculosis Vaccine Clinical Trial
- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) has started the phase I clinical trial of the AdVac-based tuberculosis vaccine it is developing in partnership with The AERAS Global TB Vaccine Foundation. The clinical trial will be an open-label study that will test the vaccine in...
- Research articles 2006-12-01
- Fast Track Systems Accelerates Trial Planning; New TrialSpace Resource and Cost Estimator Enables Data-Driven Planning of Clinical Trial Resources and Costs
- Business Editors & Health/Medical/High-Tech Writers SAN MATEO, Calif.--BUSINESS WIRE--Dec. 9, 2002 Fast Track Systems, a clinical development optimization company, today announced the general availability of its TrialSpaceTM Resource and Cost EstimatorTM, a unique, data-driven enterprise application to improve clinical trial planning. Using this innovative product, clinical trial professionals...
- Research articles 2002-12-09
- Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis.(Clinical report)
- EVRY, France, June 25 /PRNewswire/ -- Novagali Pharma, an emerging pharmaceutical company specialized in ophthalmology presents positive results of its pivotal phase III clinical trial positive results from the Phase III clinical study of Vekacia EVRY, France, June 25 /PRNewswire/ -- ...
- Research articles 2007-06-25
- Curis Provides Update on Ongoing Basal Cell Carcinoma Phase I Clinical Trial
- CAMBRIDGE, Mass. -- Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company, today provided an update on a Phase I clinical trial for the treatment of basal cell carcinoma. This Phase I clinical trial is being conducted by Genentech (NYSE: DNA) and Curis, and is expected to be completed in...
- Research articles 2006-01-23
- ReGen Announces Completion Of CMI Clinical Trial Surgeries
- Business Editors FRANKLIN LAKES, N.J.--BUSINESS WIRE--Nov. 20, 2002 ReGen Biologics, Inc. (OTC: RGBI), today announced that all surgeries have been completed for the required enrollment in its U.S. clinical trial for the Collagen Meniscus Implant ("CMI"), the largest-ever U.S. based multicenter clinical trial involving the meniscus of the...
- Research articles 2002-11-20
- GlycoGenesys, Inc. Announces Additional Cancer Indication for GCS-100LE Clinical Trial Program; Company Committed to Forming Strategic Alliance in 2005
- BOSTON -- GlycoGenesys, Inc., (NASDAQ: GLGS), a biotechnology company focused on carbohydrate-based drug development, announced a new indication, chronic lymphocytic leukemia CLL, for its cancer clinical trial program for GCS-100LE. The addition of CLL to its clinical trial program positions GlycoGenesys to pursue approval in two indications for unmet medical...
- Research articles 2005-01-25
- Devon Health Building Clinical Trial Network; Quality Doctors Being Recruited to Participate in Clinical Trials
- KING OF PRUSSIA, Pa. -- Devon Health Services, Inc., the Northeast's most extensive PPO and National Healthcare Cost Management Company, is actively recruiting quality physicians to participate in the Devon Health Clinical Trial Network. A clinical trial is a study of a new drug, surgical procedure, or other therapy...
- Research articles 2005-06-15
- MethylGene Initiates Phase I/II Combination Clinical Trial with its Proprietary HDAC Inhibitor, MGCD0103, and Gemzar'R' in Patients with Pancreatic Cancer.
- MONTREAL, QUEBEC, Oct 25, 2006 CCNMatthews via COMTEX -- MethylGene Inc. (TSX:MYG), along with its partner Pharmion Corporation (NASDAQ:PHRM), today announced the initiation of a Phase I/II clinical trial (Trial 006) evaluating its isotype-specific MONTREAL, QUEBEC, Oct 25, 2006 CCNMatthews via COMTEX -- MethylGene Inc....
- Research articles 2006-10-25
- LILLY (ELI) & COMPANY - Additional Clinical Trial Required for Ruboxistaurin.
- Lilly Announces FDA Requirement of Additional Clinical Trial Before Ruboxistaurin Could Be Approved for Treatment of Diabetic Retinopathy Additional Trial Would Take Up To Five Years to Complete; Lilly Currently Evaluating Options INDIANAPOLIS, Lilly Announces FDA Requirement of Additional Clinical...
- Research articles 2006-09-29
- Crucell and AERAS Announce Start of Tuberculosis Vaccine Clinical Trial
- Leiden, The Netherlands, October 25, 2006 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced that it has started the phase I clinical trial of the AdVac®-based tuberculosis vaccine it is developing in...
- Research articles 2006-10-25
- Millennium and Schering-Plough Initiate Clinical Trial With INTEGRILIN (Eptifibatide) Injection in Early Use Acute Coronary Syndrome Setting
- In this article Millennium Pharmaceuticals, Inc. and Schering-Plough Corporation discusses the initiation of a multicenter phase IIIb clinical trial to evaluate the benefit of INTEGRILIN when administered early to high-risk patients experiencing non-ST-segment elevation acute coronary syndrome. The trial, known as EARLY ACS (Early Glycoprotein IIb-IIIa Inhibition in Non-ST-segment Elevation...
- White papers
Neighboring Terms
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
